CREATD INC (CRTD)

US2252651078 - Common Stock

0.195  -0.18 (-48.11%)

After market: 0.2 +0.01 (+2.56%)

Fundamental Rating

2

CRTD gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 68 industry peers in the Interactive Media & Services industry. Both the profitability and financial health of CRTD have multiple concerns. While showing a medium growth rate, CRTD is valued expensive at the moment.



0

1. Profitability

1.1 Basic Checks

In the past year CRTD has reported negative net income.
In the past 5 years CRTD always reported negative net income.
CRTD had a negative operating cash flow in each of the past 5 years.

1.2 Ratios

Industry RankSector Rank
ROA -362.19%
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Industry RankSector Rank
OM -593.73%
PM (TTM) -659.9%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

1

2. Health

2.1 Basic Checks

CRTD does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CRTD has been increased compared to 1 year ago.
CRTD has a better debt/assets ratio than last year.

2.2 Solvency

Based on the Altman-Z score of -29.40, we must say that CRTD is in the distress zone and has some risk of bankruptcy.
CRTD has a Debt/Equity ratio of -0.01. This is a healthy value indicating a solid balance between debt and equity.
Industry RankSector Rank
Debt/Equity -0.01
Debt/FCF N/A
Altman-Z -29.4
ROIC/WACCN/A
WACC11.29%

2.3 Liquidity

CRTD has a Current Ratio of 0.27. This is a bad value and indicates that CRTD is not financially healthy enough and could expect problems in meeting its short term obligations.
CRTD has a Quick Ratio of 0.27. This is a bad value and indicates that CRTD is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.27
Quick Ratio 0.23

6

3. Growth

3.1 Past

CRTD shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 55.35%, which is quite impressive.
CRTD shows a strong growth in Revenue. In the last year, the Revenue has grown by 141.63%.
The Revenue has been growing by 81.22% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)55.35%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q46.67%
Revenue 1Y (TTM)141.63%
Revenue growth 3Y277.38%
Revenue growth 5Y81.22%
Revenue growth Q2Q67.47%

3.2 Future

Based on estimates for the next years, CRTD will show a very negative growth in Earnings Per Share. The EPS will decrease by -23.02% on average per year.
The Revenue is expected to grow by 148.15% on average over the next years. This is a very strong growth
EPS Next Y-51.33%
EPS Next 2Y-23.02%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year146.31%
Revenue Next 2Y148.15%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CRTD. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CRTD. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA -0.1

4.3 Compensation for Growth

A cheap valuation may be justified as CRTD's earnings are expected to decrease with -23.02% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-23.02%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for CRTD!.
Industry RankSector Rank
Dividend Yield N/A

CREATD INC

NASDAQ:CRTD (9/6/2022, 7:00:01 PM)

After market: 0.2 +0.01 (+2.56%)

0.195

-0.18 (-48.11%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryInteractive Media & Services
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap647.39K
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -362.19%
ROE N/A
ROCE
ROIC
ROICexc
ROICexgc
OM -593.73%
PM (TTM) -659.9%
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.55
Health
Industry RankSector Rank
Debt/Equity -0.01
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.27
Quick Ratio 0.23
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)55.35%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y-51.33%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)141.63%
Revenue growth 3Y277.38%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y